Clinical Trials List
2012-07-01 - 2017-12-31
Phase II
Terminated5
-
Trial Applicant
Clinipace Taiwan Co., Ltd
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHUNG-HSIN CHEN Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Chen Division of Urology
- Hsi-Chin Wu Division of Urology
- Chi-Ping Huang Division of Urology
- Chi-Rei Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- 熊小澐 Division of Radiology
- Shian-Shiang Wang Division of Urology
- Jian-Ri Li Division of Urology
- Cheng-Kuang Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Cheng Chang Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 鄭元佐 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
40 participants
